Strategic Network PetCure Oncology operates a national network of veterinary cancer centers delivering stereotactic radiotherapy (SRS/SRT), signaling potential for cross-facility referrals, shared protocols, and centralized access for partners seeking expanded oncology capabilities.

Expert Oversight A Scientific Advisory Board comprising board-certified oncologists and medical physics experts indicates a readiness to collaborate on joint clinical studies, training programs, and consensus-driven protocols that could attract academic and referral partners.

Tech-Enabled Care Adoption of advanced radiotherapy tech and a modern tech stack (various advertising platforms, data-driven outreach, and patient engagement tools) suggests opportunities to partner on digital marketing co-branding, analytics-driven referral campaigns, and patient acquisition services.

Growth Footprint Expansion into multiple markets including Houston and other states demonstrates a growth trajectory and potential sales opportunities with regional practices looking to add SRS/SRT capabilities or to participate in joint ventures and shared services.

Financial Scale Current revenue range and modest employee size imply openness to partnerships, equipment procurement, and service-level collaborations with larger veterinary networks seeking scalable oncology solutions and standardized care across centers.